Purpose: A proposed mechanism for the enhanced effectiveness of hyperthermia and doxorubicin (Dox) combinations is increased intracellular Dox concentrations resulting from heat-induced cell stress. The purpose of this study was to determine whether specific varied Dox and heat combinations produce measurable effects greater than the additive combination, and whether these effects can be attributed to heat-induced increases in intracellular Dox concentrations. Methods: HCT116, HT29 and CT26 cells were exposed to Dox and water bath heating independently. A clonogenic survival assay was used to determine cell killing and intracellular Dox concentrations were measured in HCT116 cells with mass spectrometry. Cells were exposed to heating at 42 ...
Chemotherapy is cytotoxic to various cancer cells and as well as normal cells. Thus, treatments that...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...
Cell survival in response to doxorubicin (Dx) and cis-diammine-dichloroplatinum (cis-Pt) administrat...
Melanoma is the deadliest form of skin cancer, and its incidence has alarmingly increased in the las...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
PURPOSE: Hyperthermia combined with chemotherapy is not a novel cancer treatment. However, the worki...
(A) Surviving fraction as function of DOX concentration for 1 hour at 37, 42 or 43°C. Cells were exp...
Contains fulltext : 48580.pdf (publisher's version ) (Closed access)PURPOSE: Hyper...
Melanoma is a drug-resistant cancer, representing a serious challenge in cancer treatment. Dacarbazi...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
Hyperthermia (HPT) at 43 degrees C for 30 min increased the cytotoxic activity of doxorubicin agains...
Hyperthermia (HPT) at 43 degrees C for 30 min increased the cytotoxic activity of doxorubicin agains...
INTRODUCTION: Hyperthermia and mitomycin-C (MMC) have given very encouraging results in several clin...
Chemotherapy is cytotoxic to various cancer cells and as well as normal cells. Thus, treatments that...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...
Cell survival in response to doxorubicin (Dx) and cis-diammine-dichloroplatinum (cis-Pt) administrat...
Melanoma is the deadliest form of skin cancer, and its incidence has alarmingly increased in the las...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
PURPOSE: Hyperthermia combined with chemotherapy is not a novel cancer treatment. However, the worki...
(A) Surviving fraction as function of DOX concentration for 1 hour at 37, 42 or 43°C. Cells were exp...
Contains fulltext : 48580.pdf (publisher's version ) (Closed access)PURPOSE: Hyper...
Melanoma is a drug-resistant cancer, representing a serious challenge in cancer treatment. Dacarbazi...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
Hyperthermia is usually used at a sub-lethal level in cancer treatment to potentiate the effects of ...
Hyperthermia (HPT) at 43 degrees C for 30 min increased the cytotoxic activity of doxorubicin agains...
Hyperthermia (HPT) at 43 degrees C for 30 min increased the cytotoxic activity of doxorubicin agains...
INTRODUCTION: Hyperthermia and mitomycin-C (MMC) have given very encouraging results in several clin...
Chemotherapy is cytotoxic to various cancer cells and as well as normal cells. Thus, treatments that...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDD...